Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) has a beta value of -0.17 and has seen 1.04 million shares traded in the recent trading session. The company, currently valued at $4.05M, closed the recent trade at $1.80 per share which meant it lost -$0.03 on the day or -1.64% during that session. The LIXT stock price is -145.56% off its 52-week high price of $4.42 and 13.89% above the 52-week low of $1.55. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.16 million shares traded. The 3-month trading volume is 57.20K shares.
Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) trade information
Sporting -1.64% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the LIXT stock price touched $1.80 or saw a rise of 3.23%. Year-to-date, Lixte Biotechnology Holdings Inc shares have moved -23.40%, while the 5-day performance has seen it change -4.26%. Over the past 30 days, the shares of Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) have changed -19.10%. Short interest in the company has seen 9565.0 shares shorted with days to cover at 1.85.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Lixte Biotechnology Holdings Inc (LIXT) estimates and forecasts
The company’s shares have lost -27.13% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -4.05% over the past 5 years.
LIXT Dividends
Lixte Biotechnology Holdings Inc is expected to release its next earnings report in October this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Lixte Biotechnology Holdings Inc (NASDAQ:LIXT)’s Major holders
Insiders own 20.48% of the company shares, while shares held by institutions stand at 7.93% with a share float percentage of 9.97%. Investors are also buoyed by the number of investors in a company, with Lixte Biotechnology Holdings Inc having a total of 6.0 institutions that hold shares in the company.
